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Increasing evidence suggests that microRNAs may
play important roles in regulating self-renewal and
differentiation in mammalian stem cells (SCs). Here,
we explore this issue in skin. We first characterize
microRNA expression profiles of skin SCs versus
their committed proliferative progenies and identify
a microRNA subset associating with ‘‘stemness.’’
Of these, miR-125b is dramatically downregulated
in early SC progeny. We engineer an inducible mice
system and show that when miR-125b is sustained
in SC progenies, tissue balance is reversibly skewed
toward stemness at the expense of epidermal, oil-
gland, and HF differentiation. Using gain- and loss-
of-function in vitro, we further implicate miR-125b
as a repressor of SC differentiation. In vivo, tran-
scripts repressed upon miR-125b induction are
enriched >700% for predicted miR-125b targets nor-
mally downregulated upon SC-lineage commitment.
We verify some of these miR-125b targets, and show
that Blimp1 and VDR in particular can account for
many tissue imbalances we see when miR-125b is
deregulated.
INTRODUCTION
Stem cells (SCs) possess intrinsic long-term properties that
enable them to self-renew and differentiate into the specialized
cell types of the tissue in which they reside. They are the basis
of tissue homeostasis, wound-repair, and likely tumor growth
as well (Rossi et al., 2008;Weissman, 2000). Elucidating the tran-
scriptional and posttranscriptional mechanisms that control
these properties is essential for understanding the basic princi-
ples of animal development, as well as realizing their therapeutic
potential for regenerative medicine.
One excellent system to study SCs is the mouse skin, where
distinct populations of epithelial stem cells give rise to different
tissue structures with distinct turnover rates. SCs within the
innermost (basal) layer of the interfollicular epidermis (IFE) and
hair follicle (HF) orifice (infundibulum) generate a stratified, termi-
nally differentiated epidermis, which turns over at a relatively294 Cell Stem Cell 8, 294–308, March 4, 2011 ª2011 Elsevier Inc.constant rate in adult mice. Sebaceous gland (SG) SCs within
the junctional zone of the HF outer root sheath (ORS) generate
proliferative precursors for the terminally differentiated sebo-
cytes that secrete lubricating oil for the hair and skin surface
(Horsley et al., 2006; Jensen et al., 2009; Snippert et al., 2010).
Just below this zone is the ‘‘bulge,’’ a niche for the infrequently
cycling SCs that fuel the hair cycle (Blanpain and Fuchs, 2009;
Hsu et al., 2011). During the growth phase (anagen), the HF
below the bulge regenerates and produces hair for several
weeks. The HF then triggers a rapid destructive phase (catagen),
which is followed by a quiescent resting phase (telogen), which
can last for weeks (Cotsarelis et al., 1990; Oshima et al., 2001;
Taylor et al., 2000). HF-SCs in the bulge are typically slow
cycling, but they are activated at the start of the growth phase.
The earliest progeny are thought to be cells along the ORS,
which progress to become the transit-amplifying (TA) matrix at
the bulb of the HF. After a brief period of active proliferation,
matrix cells then terminally differentiate into one of the six distinct
layers of the hair shaft and its channel, the inner root sheath (IRS)
(Blanpain and Fuchs, 2009).
IFE, SG, and HF SCs share certain features, which include
their expression of transcription factor p63 and keratins K14
and K5, as well as their high levels of integrins, reflective of their
adherence to the underlying basement membrane that is rich in
extracellular matrix and growth factors. Their close relation is
further evidenced by the fact that, upon injury, HF-SCs can
give rise to IFE and SG progenitors (Blanpain et al., 2004;
Claudinot et al., 2005; Horsley et al., 2006; Levy et al., 2005;
Morris et al., 2004; Nowak et al., 2008; Tumbar et al., 2004),
a feature also suggested for IFE SCs (Ito et al., 2007). However,
bulge SCs are distinguished from other skin SCs by their
expression of CD34, Lgr5, and K15, and in addition, a group of
essential transcription factors (Sox9, Nfatc1, Tcf3, Tcf4, and
Lhx2) (Blanpain and Fuchs, 2009). Most of these markers and
the slow-cycling properties of bulge HF-SCs are already evident
in neonatal mice prior to completion of HF and SG morphogen-
esis (Nowak et al., 2008).
Posttranscriptional regulation in skin is also important, as evi-
denced by recent studies on microRNAs (miRNAs), which typi-
cally dampen expression of proteins by inducing degradation
or translational inhibition of their target mRNAs (Ambros, 2004;
Bartel, 2004). Most of the evidence comes from K14-Cre medi-
ated conditional loss-of-function studies on core components
of the machinery that generates these small (20- to 24-nucleo-
tide) noncoding regulatory RNAs (Andl et al., 2006; Yi and Fuchs,
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embryonic epidermis and HFs, and temporal analyses at the
tissue level suggest that they have distinct patterns of expression
in these twoepithelia (Yi et al., 2006, 2009).Of these,miR-203has
been identified as an inhibitor of ‘‘stemness’’ in IFE, where it is
thought to act by repressing p63 translation as cells commit
to differentiate (Lena et al., 2008; Yi et al., 2008). Conversely,
miR-205 is expressed throughout epidermis, where it is thought
to function by regulating Akt activity and guard against apoptosis
(Yu et al., 2010). The functions of miRNAs in SG and HF SCs
remain unexplored, although their significance is suggested
by the evagination of hair buds lacking miRNAs (Andl et al.,
2006; Yi et al., 2006, 2009) and by the severely restricted HF
and SG development seen in the few K14-Cre X Dicer mutant
mice that survive into neonatal life (Andl et al., 2006).
Given increasing roles of miRNAs in regulating embryonic and
adult SCs (Crist and Buckingham, 2009; Delaloy et al., 2010; Guo
et al., 2010; Hatfield et al., 2005; Li and Gregory, 2008; Zhao
et al., 2010), the relevance of specific miRNAs to skin SC biology
merited further exploration. In the present study, we generated
miRNA signatures for four different populations of keratinocytes
that possess proliferative capacity within postnatal day 4 (P4)
skin. To accomplish this goal, we exploited their differential
expression of integrins, K14 and Sox9. We were particularly
interested in miRNAs upregulated in P4 GFP+ ORS cells from
Sox9GFP transgenic mice, given that lineage tracing revealed
that these cells not only give rise to the adult HF and SG SCs,
but also contribute to long-term repair of IFE upon wounding
(Nowak et al., 2008).
Through miRNA array analysis, we show that, surprisingly, the
miRNA signature of the early Sox9GFP-expressing cells is
closely related to that of IFE basal cells but strikingly different
from non-bulge ORS or matrix. We focused on miR-125b as an
miRNA that is strongly expressed in Sox9 promoter-active cells,
somewhat expressed in basal epidermal cells, and significantly
downregulated in ORS and matrix. We show that by sustaining
miR-125b throughout K14-expressing cells, the transition from
stemness to committed progenitor is markedly retarded both
in vivo and in vitro. The consequences in vivo are dire—a hyper-
thickened epidermis, enlarged SGs, and a failure to generate
a hair coat—but are fully reversible upon restoring normal
miR-125b regulation. We isolate and profile transcripts that are
expressed by WT early bulge and nonbulge progeny but
repressed when miR-125b is sustained in progeny. Interestingly,
transcripts repressed upon miR-125b induction are >700%
enriched for conserved predicted miR-125b targets, which are
normally downregulated in early bulge SCs versus their imme-
diate early progenies. This enabled us to hone in on two key
genes encoding transcription factors Blimp1 and VDR. We
show that both are bona fide miR-125b targets in skin and can
account for many of the phenotypic abnormalities that we see.
RESULTS
Purification of Early Bulge Cells
by Fluorescence-Activated Cell Sorting
Our purification scheme was based upon transgenic mice coex-
pressing K14-RFP and Sox9-EGFP (Supplemental Experimental
Procedures). Despite some EGFP in suprabasal cells of theupper HF near the hair shaft, only the early ORS region encom-
passing the future bulge and junctional zones showed strong
colabeling of EGFP/Sox9, a6 integrin, and RFP/K14, thereby
providing specificity for what we hereafter refer to as ‘‘early bulge
cells’’ (Figure 1A). After enzymatically separating epidermis and
dermis (including HFs) and generating single-cell suspensions,
we used FACS to fractionate populations containing early bulge
cells (Early Bulge) (RFPhiGFPhia6hiLinneg), ORS cells excluding
the early bulge region (RFPhiGFPnega6hiLinneg) (mostly ORS cells
below the bulge), transit-amplifying matrix cells (Matrix)
(RFPloGFPnega6loLinneg) and IFE basal cells (Basal) (RFPhia6hi
Linneg) (Figures 1A–1C).
Real-time PCR verified the efficacy of our strategy and lineage
assignments (Figure 1D). As expected, Sox9 mRNA levels were
highest in the RFPhiGFPhia6hiLinneg cells. This population was
also enriched for other early bulge SCmarkers, includingNfatc1,
Tcf3, and Lhx2 (Blanpain and Fuchs, 2009), as well as junctional
zone markers, Lgr6 and Lrig1 (Figure 1D; Table S1). Consistent
with their known expression patterns (Horsley et al., 2008;
Blanpain and Fuchs, 2009), Nfatc1 was downregulated in the
nonbulge ORS population, while Sox9, Tcf3, Lhx2, and Lgr5
persisted (Figure 1D; Table S1). By contrast, the IFE and
infundibulum marker Sca-1 was enriched in RFPhia6hiLinneg
basal cells, while matrix marker Msx2 was prominent in the
RFPloGFPnega6loLinneg pool. As negative controls, c-kit (melano-
cytes) was not detected, and vimentin (fibroblasts) was only
found at low levels in the matrix fraction. Taken together, these
results confirmed our designations of these populations and
their purity.
Defining a miRNA Signature for Early Bulge Cells
To identify miRNAs that are preferentially expressed in each
fluorescence-activated cell sorting (FACS)-purified fraction, we
performed miRNA microarrays (Experimental Procedures). Two
interesting observations emerged upon analyzing these data.
First, unsupervised hierarchical clustering revealed that the
miRNA profile of the early bulge fraction was more closely
related to the epidermal than ORS or matrix fractions (Figure 2A).
This was surprising because bulge and ORS share more tran-
scriptional similarities than basal epidermis. Second, individual
members of an miRNA family that possess a common ‘‘seed’’
sequence tended to exhibit similar expression patterns among
different skin cell populations (Figure 2B). The coordinate
expression of functionally related miRNAs suggested a possible
means of reinforcing the regulation of key miRNA target genes
for these SC populations.
We selected four miRNAs with divergent expression
patterns—miR-125b, miR-24, miR-205, and miR-31—and em-
ployed Taqman probes to verify their expression by RT-PCR
(Figure 2C). MiR-125b was notable for its strong enrichment in
the early bulge fraction. In situ hybridization confirmed its local-
ized expression in the upper ORS (Figures 2D and 2E).
MiR-125b was particularly interesting in that it is a mammalian
ortholog of C. elegans lin-4miRNA, the first animal miRNA char-
acterized. InC. elegans, lin-4 targets lin-14 and lin-28 to regulate
temporally dependent developmental programs (Lagos-Quin-
tana et al., 2002; Lee et al., 1993; Moss et al., 1997; Wightman
et al., 1993). The lin-4(miR-125)-lin-28 regulation pair has been
evolutionarily conserved and functions critically in mammalianCell Stem Cell 8, 294–308, March 4, 2011 ª2011 Elsevier Inc. 295
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Figure 1. FACS Purifications of Backskin Populations Possessing Proliferative Capacity
Mice used are K14-RFP/Sox9-EGFP at P4.
(A) Immunofluorescence for markers used in purification. Bu, early bulge; ORS, non-bulgeORS; Mx, matrix; Epi, IFE basal layer; Inf, infundibulum; SG, sebaceous
gland. Color coding is according to secondary antibodies (Abs) used. Scale bar represents 50 mm.
(B and C) FACS purifications. (B) HFs: RFPhiGFPhia6hiLinneg Early Bulge, RFPloGFPa6+Linneg non-bulge ORS, RFPloGFPa6loLinneg Matrix, and RFP+Linneg
reference cells (RFP All). (C) IFE: RFPhia6hiLinneg IFE (Basal).
(D) RT-PCR. Vertical axis represents Log2-transformed Fold of enrichment comparing with the RFP-All reference population. Error bars represent standard error.
GAPDH was used as a reference gene for all RT-PCR.
See also Table S1.
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Belasco, 2005). miR-125b’s localization in the upper ORS made
it a candidate for regulating early bulge SCs. However, because
lin-28 was not expressed in postembryonic skin, miR-125b
must control other targets in the HF.
Maintaining miR-125b in Skin SC Progeny Causes
Striking Pleiotropic Phenotypes
To explore miR-125b’s role in skin SCs, we first devised
a strategy to sustain its expression in nonbulge ORS, where it296 Cell Stem Cell 8, 294–308, March 4, 2011 ª2011 Elsevier Inc.is normally downregulated, and to upregulate it in basal
epidermal cells, where it is normally expressed at lower levels
than in bulge. For this purpose, we engineered three lines of
transgenicmice to expressmiR-125b under the control of a tetra-
cycline regulatory element (TRE) (Figure 3A). The TRE-miR-125b
mice were then mated with our previously described transgenic
line that expresses the tetracycline-sensitive transactivator,
rtTA2S-M2-VP16 (rtTA), controlled by a keratin 14 (K14)
promoter that is active in ORS and basal epidermis (Nguyen
et al., 2006). Within 24 hr after tetracycline (doxycycline, Dox)
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Figure 2. Differential Expression of miRNAs
(A) Unsupervised hierarchical clustering and heat map display of miRNA expression profiles of FACS-purified populations. Comparisons are normalized to the
RFP-All reference cell population. Each row represents an individual miRNA. Each column represents an independent sample. Two to three biological replicates
were analyzed for each population. Red represents downregulation, while green represents upregulation compared to RFP-All.
(B) Histogram of Pearson’s correlation coefficient of expression patterns between all possible miRNAs (blue bars) or between miRNAs that belong to the same
miRNA family (intrafamily, red bars). The correlation of expression was calculated based on the miRNA expression profiles presented in (A).
(C) miRNA-microarray results and RT-PCR verification of expression patterns of the miRs indicated. U6 was used as the reference gene in RT-PCR. Error bars
represent standard error.
(D and E)miR-125b in situ hybridizations of WT P4 and P17 backskins. In situ signals (black) were developed by BMpurple substrate: K5 (green) in ORS and basal
IFE. Scale bars represent 50 mm.
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(DTG) exhibited robust miR-125b expression in all K14(+) cells,
including basal epidermis andORS (Figure 3B). MiR-125b induc-
tion was confirmed by RT-PCR on FACS-isolated DTGORS cells
(Experimental Procedures). Strong and specific induction of
miR-125b was observed without significant disturbance of other
unrelated miRNAs (Figure 3C).
Without Dox, the mice developed normally and were morpho-
logically indistinguishable from wild-type (WT) littermates (Fig-
ure 3D). When Dox was administered to neonatal mice during
the growth phase of the first hair coat (P3), hair growth wasinhibited, a feature which became obvious 10 days later (Fig-
ure 3D). When Dox was given during the first resting phase
(P21) and then monitored through one entire hair cycle to the
second resting phase (P48), the new hair coat never emerged
(Figure 3D). As long as miR-125b was sustained, baldness per-
sisted. All three DTG lines behaved analogously, although the
progression to baldness varied among them, likely reflective of
their different miR-125b expression levels (Figure S1).
Hair growth inhibition was best visualized by administering
Dox at P56 during the prolonged telogen phase of the 2nd
postnatal hair cycle, and then waxing backskins 2 days later toCell Stem Cell 8, 294–308, March 4, 2011 ª2011 Elsevier Inc. 297
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Figure 3. Sustained miR-125b Blocks Hair Growth
(A) Schematic of constructs used to generate DTG mice.
(B) miR-125b in situ hybridizations of P4 backskin sections
harvested after 24 hr Dox induction. In situ signal, black;
DAPI, blue; TRE, TRE-miR-125b single transgenic; DTG,
double transgenic. Scale bar represents 50 mm. Note
that high miR-125b levels are no longer confined to HF-
SCs but are now expanded to early progeny.
(C) Taqman RT-PCR analysis of miRNAs in FACS-sorted
P4 stage backskin ORS cells. Error bars represent stan-
dard error.
(D) Appearance of DTG andWT littermates given Dox at P3
(anagen) or P21 (telogen) and photographed at ages indi-
cated.
(E) Mice were given Dox at P56, and at P58, the upper
backskins were waxed and lower parts were shaved.
Animals were photographed at ages indicated.
See also Figures S1 and S2.
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nous initiation of a new hair cycle. In WT mice, the coat regrew
in the depilated area by P71, while miR-125b-induced mice still
displayed the bald patch (Figure 3E). Intriguingly, while hair
growth was markedly impaired in DTG mice, growth of some
other skin tissues and appendages was noticeably accentuated.
This was particularly true for the lips, nails, and anogenital areas
in which the K14 promoter is active (Figures S2A and S2B).
Moreover, when Dox was administered to DTG mice, the hair298 Cell Stem Cell 8, 294–308, March 4, 2011 ª2011 Elsevier Inc.coat became greasy prior to its loss. Closer
inspection revealed greatly enlarged SGs,
whose sebocytes stain with oil red O (Figure 4A).
MiR-125b Regulates SG Development By
Targeting Blimp1 Through a Conserved
30UTR Binding Site
The enlarged SGs accompanying miR-125b
induction were reminiscent of those in mice
conditionally targeted for Blimp1, which en-
codes a transcriptional repressor normally
expressed by K14-promoter-active sebocyte
progenitors (Horsley et al., 2006). Indeed, immu-
nofluorescence microscopy revealed a marked
reduction in Blimp1 protein following induction
of miR-125b (Figure 4B). RT-PCR confirmed
that Blimp1 mRNA levels were also strongly
downregulated in Dox-induced DTG skin.
Analogous to theBlimp1 cKO animals, the sebo-
cyte marker PPARg was strongly upregulated
(Figure 4C).
The 30UTR of Blimp1 mRNA is predicted by
TargetScan (Lewis et al., 2005) to contain
a single miR-125b binding site that is well
conserved from amphibian to mammals. To
test the hypothesis that Blimp1 mRNA may be
a direct target of miR-125b in skin, we con-
structed a luciferase reporter for WT Blimp1
30UTR, as well as a control reporter in which
the miR-125b binding site of the Blimp1 30UTR
was mutated (Figure 4D). Luciferase reporterassays were then carried out in primary keratinocytes (MK)
cultured from P0 epidermis of WT skin and transfected with
synthesized miR-125b precursor (Pre-miR-125b) or control
Pre-miR.
Elevated miR-125b resulted in strong repression of the WT
Blimp1 30UTR reporter, but not a mutant Blimp1 30UTR reporter
lacking the miR-125b binding site (Figure 4E). Furthermore,
when miR-125b was repressed by transfecting antisense LNA
probes against miR-125b into cultured MK, WT Blimp1 30UTR
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Figure 4. Enlarged Sebaceous Glands in DTG
Mice Traced to miR-125b-Induced Suppression
of Blimp1
(A) Whole-mount Oil Red O staining of tail skin of P72 DTG
and WT littermates (+Dox a/P56).
(B) Anti-Blimp1 immunofluorescence of backskin sections
of P13 mice (+Dox a/P3).
(C) RT-PCR of P79 tail skin mRNAs of P79 mice
(+Dox a/P21). GAPDH, reference.
(D) Pairing between predicted miR-125b binding site on
Blimp1 30UTR and mmu-miR-125b. The seed region of
miR-125b is highlighted.
(E and F) Relative luciferase activity of WT and Mutated
(Mut) Blimp1 30UTR reporters in culturedMKwhen cotrans-
fected with pre-miRNA precursors (E) or antisense LNA
knockdown probes (F) compared with their corresponding
controls. The vector control is CMV-PGL4. The effective-
ness of miR-125b overexpression by pre-miR-125b
precursor and miR-125b knockdown by anti-miR-125b
LNA was confirmed by the activity of miR-125b sensor.
All error bars represent standard error unless otherwise
indicated. All scale bars represent 50 mm unless otherwise
indicated.
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control reporter (Figure 4F). Taken together, these data indicate
that Blimp1 mRNA is a direct and functionally relevant target of
miR-125b in skin keratinocytes.
MiR-125b Represses Hair Differentiation
While the link between miR-125b and Blimp1 was sufficient to
account for the SG phenotype, it did not explain the hair growth
defect observed in our mice. To decipher how sustained
miR-125b expression might induce baldness, we first examined
backskin histology from strain-, sex- and age-matched litter-
mates of Dox-induced DTG versus WT (or single transgenic)
mice. Surprisingly, near the end of the first anagen, when WT
littermate HFs had reached maximal length (P13, Dox-induced
since P3), DTG HFs were much longer, exhibiting a highly elon-
gated ORS (Figure 5A). Immunofluorescence microscopy
showed proper expression of ORS markers K14 and b4 integrin
but a marked reduction in markers of matrix-derived hair shaft
and inner root sheath (IRS) cells (Figure 5B).Cell Stem Cell 8The dearth of hair shaft and IRS cells could
arise from repressed terminal differentiation, an
increase in cell death, or an impaired ability of
matrix to fuel production of these lineages. To
distinguish between these possibilities, we
examined matrix size and proliferative potential.
When P13 mice were pulsed by a single injection
with the nucleotide analog BrdU and sampled
after 4 hr, S phase cells were primarily in matrix
(Figure 5C). Compared to WT, DTG HFs showed
a >30% reduction in labeled matrix cells. By
11 hr, many of these labeled cells in WT HFs
had moved into the nondividing precortex,
reflecting their normal progression of differentia-
tion. By contrast, an 33 reduction was seen in
labeled DTG precortical cells (Figure 5C). Taken
together, these data revealed reductions bothin the number of dividing transiently amplifying (TA) cells in the
matrix and their rate of differentiation into hair shaft and IRS
lineages.
The underlying basis for these lineage defects did not appear
to reside in enhanced cell death (apoptosis), as evidenced by the
relative lack of activated caspase 3 staining, except for the core
of the hair shaft, also positive in WT HFs (Figure 5D). We there-
fore focused on earlier steps along the lineage, namely in the
progression of activated HF-SC progeny along the ORS to
matrix. Further analysis of BrdU+ cells revealed a modest reduc-
tion in labeled cells within the lower DTG ORS during both 4 hr
and 11 hr labeling periods (Figure 5E). Unexpectedly however,
the upper ORS, including the bulge region, showed an 6- to
73 enhancement in S phase cells in these HFs (Figure 5F).
This was accompanied by hyperthickening of this zone (Fig-
ure 5G), a feature not seen in mid and lower ORS (Figure 5B).
Taken together with the marked elongation of the mid/lower
DTG ORS, these data suggest that sustained miR-125b in the
ORS increases the number of cell divisions that early bulge cells, 294–308, March 4, 2011 ª2011 Elsevier Inc. 299
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commitment and progression along the lineage.MiR-125b Inhibits the Differentiation of Skin SCs
Without Affecting Their Maintenance or Activation
Thus far, our data suggested that stemness may still be main-
tainedwhenmiR-125b cannot be downregulated in HF-SC prog-
enies. To examine this possibility, we first looked at bulge
markers Lhx2, Sox9, Tcf4, Nfatc1, and CD34 in Dox-induced
DTG skins of adult mice. With the exception of CD34, all these
markers were still present 17 days after miR-125b induction
(Figure 6A; Figure S3). To determine whether DTG skin still
possessed functional HF-SCs, we administered Dox at P21,
waited until DTG mice were bald at P58, and then either kept
mice on Dox or withdrew Dox until P94. For comparative
purposes, an area of skin fromWTmice was shaved so we could
monitor hair regeneration.
The results of the experiment are shown in Figure 6B. As
expected, only WT mice grew their hair when Dox was main-
tained. Interestingly however, by 5 week after Dox withdrawal,
DTG hair coats had largely regenerated. This happened even
when mice were kept on Dox for 4 months prior to withdrawal
(data not shown). Since the hairless phenotype was reversible,
the defect appeared to be a delay in the rate of bulge/hair
lineage progression rather than a loss of HF-SCs.
To determine whether sustained miR-125b prevented HF-SC
activation, we stimulated resting (telogen-phase) HFs by depila-
tion (waxing) to initiate a new hair cycle and then examined the
response by administering a 48 hr pulse of BrdU. Under these
conditions, >50% of Sox9+ cells in both WT and Dox-induced
DTG HFs showed active cycling (Figure 6C). Moreover, signs
of a Sox9() early matrix were also apparent at this time. Thus,
even though hair coat formation was impaired in Dox-induced
DTG mice (Figure 3E), HF-SCs were still able to respond to
a hair growth stimulus.
If miR-125b inhibits hair lineage differentiation without impair-
ing the maintenance and activation of the HF-SCs, then either
relatively undifferentiated SC-derived progeny and/or HF-SCs
themselves should accumulate in DTG HFs after Dox induction.
To test this hypothesis, we FACS-purified and cultured equiva-
lent numbers of ORS cells from HFs of DTG and control mice
and compared their ability to form large (>2 mm) colonies (holo-
clones), a characteristic of skin SCs (Barrandon and Green,
1987). Holoclone-forming efficiency was at least 33 higher in
ORS cells isolated from inducedDTG versusWTHFs (Figure 6D).
Moreover, >30% of holoclones formed by DTG ORS cells could
be serially passaged >33 in culture, a characteristic of adultFigure 5. Repressed Differentiation and Expansion of Early Bulge ORS
DTG and WT littermates were treated with Dox a/P3 and backskin sections were
(C-G).
(A) Hematoxylin and eosin staining and quantification of average HF length.
(B) Immunofluorescence for ORS, IRS, and hair shaft markers.
(C) Schematic of BrdU experiment. Immunofluorescence with Abs indicated (colo
per matrix (section) 4 hrs a/BrdU; percent of BrdU+ cells in precortex (early hair
(D) Immunostaining for activated caspase 3 shows little or no change in DTG ver
(E and F) Quantifications of BrdU+ cells in lower versus upper ORS.
(G) Immunofluorescence reveals hyperthickened upper ORS bulge region in DTG
All error bars represent standard error unless otherwise indicated. All scale barsbulge HF-SCs, but not their progeny (Greco et al., 2009) (Fig-
ure 6E). The difference in holoclone numberswas not attributable
to differences in cell attachment but, rather, to enhanced colony
initiation efficiency (where a colony is defined as R4 cells)
(Figures 6F and 6G).
The increased ability of DTG ORS to generate holoclones
could either reflect an expanded HF-SC pool or, alternatively,
an increase in the proliferation rate of early bulge progeny. To
distinguish between these possibilities, we overexpressed
miR-125b in cultured WT MK, which resulted in a significant
decline in both overall proliferation rate and the percentage of
S phase cells (Figure S4). Thus while the DTG ORS contained
a higher percentage of cells with holoclone forming and
passaging ability, elevated miR-125b in vitro made cells grow
more slowly. Together, these findings suggest that miR-125b’s
function resides in enhancing SC self-renewal rather than
promoting proliferation in general.
The effects of miR-125b on SC behavior extended to IFE
progenitors. In vivo, the IFE of Dox-induced DTG skin was hyper-
thickened, and signs of basal cell expansion were evident (Fig-
ure 6H). In vitro, cultured MK from DTG versus WT epidermis
displayed a significantly dampened response to calcium-
induced terminal differentiation when exposed to Dox (Figure 6I).
Conversely, when exposed to an antagomIR specific for miR-
125b, WT epidermal cells displayed an accentuated response
to calcium-induced differentiation (Figure 6J).Identification of Additional miR-125b Target Genes
miRNAs often downregulate themRNA level of their target genes
(Baek et al., 2008; Lim et al., 2005; Selbach et al., 2008). There-
fore, to gain further mechanistic insights underlying miR-125b’s
effects, we conducted microarray analysis on ORS cells from P4
WT and DTG mice that had been treated with Dox 1 day earlier.
We conducted our analyses on independent, duplicate matched
sets of male and female mice.
miRNAs onlymodestly regulate their targetmRNA levels (Baek
et al., 2008; Selbach et al., 2008), and our aim was to identify
early changes occurring shortly after miR-125b induction.
Hence, we chose a relatively modest cutoff, Log2(DTG/Control
Fold of change) < 0.3, for scoring a gene as being downregu-
lated in each array. Notably however, under this criterion,
TargetScan-predicted, conservedmiR-125b targets were prom-
inent within the downregulated genes of both datasets (Fig-
ure S5). Moreover, the DIANA-mirExTra algorithm (Alexiou
et al. 2010) identified miR-125b’s seed sequence ‘‘CUCAGG’’
as the most overrepresented, conserved hexamer motif within
30UTRs of these downregulated genes. Thus, our strategy toRegion in DTG HFs
either examined at P13 (A and B) unless subjected to further experimentation
r coding according to secondary Abs). Quantifications: number of BrdU+ cells
shaft) region and IRS at times indicated a/BrdU.
sus WT littermate.
HF.
represent 50 mm unless otherwise indicated.
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Figure 6. Evidence for Expansion of Stem Cell Populations in DTG Skin
(A) Immunofluorescence reveals presence of some, but not all, HF-SC markers in DTG skin (Dox a/P17; analyses a/P35).
(B) Hair coat recovery after Dox withdrawal in DTG mice. Mice were given Dox a/P21; a/P58, Dox was either continued or withdrawn as indicated.
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sensitivity.
Because sustained miR-125b resulted in analogous HF
phenotypes in male and female mice, we reasoned that the
majority of bona fide miR-125b targets in ORS cells should be
downregulated in both sexes. Consistent with this idea, 12%
of genes scoring as downregulated in both sexes upon miR-
125b induction displayed conserved miR-125b binding sites in
their 30UTRs (Figure 7A). This represented an 63 enrichment
compared to that of all ORS-expressed genes and an 33
enrichment compared to that of genes downregulated in either
sex alone. This indicated that the specificity for miR-125b target
detection would be greatly improved by focusing on the overlap
in downregulated genes in our two datasets. Hereafter, we refer
to these genes as ‘‘miR-125b downregulated genes’’ (Table S2).
Expression of a miRNA often inversely correlates with that of
its targets (Farh et al., 2005; Stark et al., 2005). Because miR-
125b is naturally enriched in early bulge but strongly downregu-
lated in nonbulge ORS, we posited that physiologically relevant
miR-125b target mRNAs should be expressed at reduced levels
in early bulge compared with nonbulge ORS. To explore this
possibility, we performed microarray analyses on mRNAs iso-
lated from our FACS-purified early bulge and nonbulge ORS
populations of P4 stage backskin HFs. Interestingly, when WT
early bulge transcripts were compared with those in ORS,
mRNAs that scored as being preferentially downregulated in
WT early bulge encompassed many mRNAs that were also
downregulated in miR-125b-induced DTG ORS (Figure 7B).
These data suggest that a significant portion of miR-125b-down-
regulated genes in the DTG ORS are endogenous miR-125b
targets in WT early bulge cells.
Thus far, our data revealed that miR-125b downregulated
genes were significantly enriched for both Targetscan-predicted
miR-125b targets and also downregulated genes in WT
early bulge versus non-bulge ORS. Remarkably, the highest
enrichment (>700%) was observed for predicted conserved
miR-125b targets that were also downregulated naturally in
miR-125b+ early bulge versus miR-125b() nonbulge ORS (Fig-
ure 7C). To derive a list of high-confidence potential miR-125b
targets, we overlapped these criteria and identified those
miR-125b downregulated genes that also (1) show downregula-
tion in WT early bulge compared to nonbulge ORS cells and (2)
possess at least one Targetscan-predicted conserved miR-
125b binding site in the 30UTR. By applying these criteria, we
generated a short-list of 33 genes as putative miR-125b targets
in the early bulge region (Table S3). From this list, we picked(C) HF-SCs are activated comparably in DTG andWT by wax-induced depilation o
HFs were analyzed and quantified 2 days later.
(D and E) 104 FACS sorted ORS cells from Dox-induced P33 DTG andWT litterma
individual large clones were picked, serially passaged, and quantified for long-ter
serial passage experiments (Greco et al., 2009), and WT ORS consists of bulge
(F and G) FACS sorted ORS cells from P59 K14H2BGFP DTG andWT HFs (Dox a/
forming efficiency is higher for DTG cells.
(H) Immunofluorescence reveals expansion of basal cells in IFE of P13 DTG bac
(I and J) RT-PCR for basal versus differentiation markers. mRNAswere fromMKs i
for 24 hr. (I), DTG MK ± Dox induction as indicated. (J), WT MK treated with anti
All error bars represent standard error unless otherwise indicated. All scale bars
See also Figures S3 and S4.three potentially interestingly targets for further verification: Vdr
encodes VDR (vitamin D receptor), involved in HF differentiation;
Trp53Inp1 encodes a positive regulator of a known miR-125b
target, p53; and Scarb1 harbors two conserved miR-125b
binding sites in the 30UTR. We validated their miR-125b binding
sites by luciferase reporter assays (Figure 7D).
MiR-125b Regulates Hair Differentiation by Repressing
VDR Expression
We focused on Vdr because it is required for HF differentiation
(Palmer et al., 2008) and its loss results in a hairless phenotype
(Li et al., 1997). Our microarray data revealed higher levels of
Vdr (1.73) in nonbulge ORS than in early bulge ORS, and this
was confirmed by immunofluorescence microscopy (Figure 7E).
In DTG ORS, VDR expression was markedly diminished, and
transcripts of genes previously identified as putative HF targets
for the VDR transcription factor (Palmer et al., 2008) were signif-
icantly downregulated both in DTG tail skin and in purified ORS
cells (Figures 7E–7H).
We confirmed the negative regulation of miR-125b on the
activity of VDR pathway by testing a VDR-responsive element
(VDRE) luciferase reporter construct in cultured DTG MK.
WhenmiR-125b expression was induced by Dox, the expression
of the VDRE reporter in response to the Vitamin D Analog
EB1089 (Palmer et al., 2008) was dramatically reduced
(Figure 7I). Conversely, in cultured WT MK, anti-miR-125b anta-
gomir treatment significantly enhanced VDRE reporter expres-
sion in response to EB1089 (Figure 7J).
Finally, if the downregulation of VDR pathway activity contrib-
utes to the miR-125b-dependent inhibition of hair differentiation,
stimulation of the pathway by ectopic VDR ligand should
dampen the phenotype. Consistent with this hypothesis, IP
injection of EB1089 partially rescued the hair growth defect in
DTG mice during depilation (waxing)-initiated hair cycle (Fig-
ure 7K). Similar rescue effects were achieved via topical applica-
tion of EB1089 solution (Figure S6).
DISCUSSION
A miRNA Signature of ‘‘Stemness’’ in the Hair Follicle
In the present study, we identified amiRNA expression signature
which specifically associates with stemness in HFs, and at least
for miR-125b, this signature is functionally relevant to tissue
homeostasis. It is tempting to speculate that by coordinately
fine-tuning the expression of a large number of proteins, miRNAs
may confer greater accuracy than transcription factors in actingf resting phase follicles. BrdU was administered beginning 1 day a/waxing and
tes were plated and after 2 weeks, cultures were either fixed and stained (D) or
m survival (E). Note: WT bulge cell colonies typically have <10% survival rate in
and nonbulge ORS. DTG ORS is highly enriched for holoclones.
P21) attach comparably 36 hr a/plating onto feeder-coated dishes, but colony-
kskin (Dox a/P3).
n either low Ca2+ (0.05 nM)media or a/switching tomediumCa2+ (0.3nM)media
-miR-125b or control scramble antagomirs as indicated.
represent 50 mm unless otherwise indicated.
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Figure 7. Identifying and Testing Putative miR-125 Targets in Skin SCs
(A) mRNAs from DTG versus WT ORS from P4 male and female mice were subjected to microarray analyses to identify a list of mRNAs downregulated by
miR-125b (see text). Shown are the percentages (%) of predicted targets for miR-125b and let-7 among the list.
(B) mRNAs from P4 WT early bulge and non-bulge ORS were subjected to microarray analyses. Shown is an accumulative percentile map for the distribution of
the miR-125b downregulated genes from (A) within these new array data.
(C) Comparisons reveal that miR-125b downregulated genes tend to be downregulated in early bulge versus nonbulge ORS.
(D) Luciferase reporter assays validate the predicted conserved miR-125b binding sites in the 30UTRs of 3 miR-125b downregulated ORS genes. Mut indicates
constructs with mutated miR-125b binding sites.
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stemness and commitment (Stark et al., 2005).
In the hair lineage, quiescent bulge SCs are known to be acti-
vated by external Wnt promoting and BMP inhibitory signals.
As progeny move downward along the ORS, they are thought
to progressively adjust their fate from that of SCs to committed
progenitors. Eventually, these cells will pass a point of no return
and end up as TAmatrix (Hsu et al., 2011). The dramatic switch in
miRNA expression profile between early bulge and nonbulge
ORS and the similarities between ORS and matrix miRNAs
suggest that miRNAs may function in regulating fate progression
through this transition point. In this regard, it was particularly
interesting thatmiR-125b exhibited a sharp downregulation early
in the lineage between bulge and adjacent ORS.Moreover, when
this switch was blocked by enforcing miR-125b expression
throughout the ORS, a gross distortion arose in the relative ratios
of cells with stemlike characteristics and those further along the
hair lineage. Notably, miR-125b did not seem to affect the main-
tenance, self-renewing ability, or activation of HF-SCs.
Within the DTG HF lineage, the upper ORS region was hyper-
thickened, while mid/lower ORS was merely elongated and the
progression to a TA cell fate was actually delayed. Given the
absence of defects in bulge SC maintenance or activation, our
findings best suit a model whereby miR-125b acts as a rheostat
whose downregulation controls the rate at which bulge proge-
nies transit through the commitment step along the lineage.
This view is further supported by the dramatic miR-125b-depen-
dent increase in holoclone-forming cells within the ORS
(including bulge). Importantly, miR-125b does not promote
proliferation per se, because when miR-125b is overexpressed
in vitro, cells grow at a significantly slower rate.
When our in vivo and in vitro data are taken together, they point
to a role for high miR-125b as a faithful definer of self-renewing,
slow-cycling SCs, while reducing miR-125b was required to
transition to a state of rapid proliferation, fate commitment,
and differentiation. Our results help to explain a myriad of seem-
ingly paradoxical findings about miR-125b, where in some cell
types, it has been reported to be an oncomir and in others,
a tumor suppressor. Our studies show how miR-125b can
suppress overall proliferation while still acting to expand stem
cell numbers and tissue/organ size.
miR-125: A Global Balancer of Stemness
and Commitment in Adult Tissues?
Another key finding was that miR-125b’s rheostat function in
governing the switch between stemness and commitment was
not limited to the HF lineage. In the normal IFE, which also
modestly expresses miR-125b in the basal layer, miR-125b(E) VDR protein is elevated in lower WT ORS, but reduced in DTG ORS.
(F) RT-PCR of Vdr and VDR targets in P79 tail skins (Dox a/P21). GAPDH, refere
(G and H) Accumulative percentile maps for the distribution of VDR targets in P4
induced miR-125b expression in DTG ORS.
(I and J) Relative activities of VDR-responsive element (VDRE) luciferase reporters
MK knocked down by anti-miR-125b or scrambled antagomirs (±Lig).
(K) Partial rescue of hair coat defect in DTG mice treated with VDR ligand. DTG a
injected with PBS or ligand (5 ng/g body weight 33/wk). Backskins were photog
All error bars represent standard error unless otherwise indicated. All scale bars
See also Figures S5 and S6 and Tables S2 and S3.elevation resulted in an expansion in the number of layers
possessing features of undifferentiated cells in vivo. Moreover
in cultured epidermal MK, calcium-induced differentiation was
enhanced when miR-125b was knocked down and repressed
when miR-125b was elevated. Finally, because Blimp1 is known
to limit SGprogenitors by repressing c-Myc (Horsley et al., 2006),
miR125b’s ability to repress Blimp1 and yield enlarged SGs was
likely rooted in an expansion of its progenitors.
In B cells, Blimp1 has been reported to induce differentiation
(Turner et al., 1994). Moreover, in vitro studies recently showed
that overexpression of miR-125b leads to Blimp1 repression
and inhibition of B cell differentiation (Gururajan et al., 2010;
Malumbres et al., 2009). One model that could explain these
seemingly paradoxical effects of Blimp1 in the SG versus
B cell lineages is that by downregulating Blimp1 in SG progeni-
tors, miR125b makes the cells go through extra rounds of prolif-
eration before they can progress into a more differentiated cell
fate. This would effectively delay differentiation and expand the
pool of less differentiated SG cells.
This same logic can potentially be applied to other lineages.
When the differentiation process is delayed and/or repressed
by miR-125b, actively cycling undifferentiated progenitors will
accumulate, generating an enlarged tissue/organ, as seen for
the lips, anogenital epithelium, nails, ORS, and epidermis in
our miR-125b-induced mice. This would also explain why in
epidermis, ORS, and SG, the most dramatic changes in prolifer-
ation seen in Dox-induced DTG skin occurred at the juncture
between SCs and their immediate progeny. Notably, this is
also the site of dramatic downregulation of miR-125b in normal
skin.
Overall, our studies implicate miR-125b as a governor of the
relative numbers of divisions that a progenitor undergoes prior
to committing to a lineage. Given that controlling this property
is likely to be of fundamental importance for maintaining
the correct size of most organs/tissues, it is intriguing that
miR-125a, a related family member, was recently found to be
a positive regulator of SC number in the hematopoietic lineage
(Guo et al., 2010). Taken together, our findings suggest that
the differentiation rheostat role for miR-125b that we’ve identi-
fied here may be a general feature of somatic SCs.
MiR-125b’s Target Genes
Our analysis of the global gene expression changes that occur
when miR-125b is sustained in HF ORS cells represents the
first effort to systematically identify the downstream targets of
miR-125b in a postnatal somatic tissue. Our data identified
800 transcripts that were downregulated within 24 hr of
miR-125b induction in both male and female mouse ORSnce gene.
ORS microarray results. VDR targets tend to be downregulated after 24 hr Dox
in (I) DTGMK ± EB1089 ligand (Lig) (107M) ± Dox induced miR-125b or (J) WT
nd K14-rtTA littermates were treated with Dox a/P48, waxed a/P50 and either
raphed a/P67.
represent 50 mm unless otherwise indicated.
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dicted conserved miR-125b targets that we also found to be
downregulated in WT early bulge versus their progenies. These
findings suggest that a considerable portion of these putative
miR-125b targets identified in our study are likely to be physio-
logically relevant.
In the current study, we focused on two miR-125b targets,
Blimp1 and Vdr. While their altered expression accounts for
many of the miR-125b-induced defects we observed, some
perturbations remain unaccounted for by these two miR-125b
targets. Notable examples are the remarkable lengthening of
HFs and enlargement of lips in DTG mice, which were not
observed in eitherBlimp1 or VDR knockout animals. By contrast,
other phenotypes, e.g., the enlarged SGs and blockage of hair
growth, were more severe in miR-125b-induced mice than in
Blimp1 or Vdr knockout animals. Moreover, because Blimp1
repression in vivo (Figure 4C) was appreciably greater than
that displayed by reporter constructs in vitro (Figure 4E), indirect
repression of Blimp1 transcription might also result from
miR-125b induction. When taken together with the fact that
excess VDR ligand only partially rescued miR-125b-induced
hair loss, it seems likely that additional miR-125b target genes
unearthed in our study but as yet untested will be necessary to
fully account for the complexities of the DTG phenotype.
In closing, it is notable that like Blimp1, Vdr has also been
reported to be amiR-125 target in a breast carcinoma line (Mohri
et al., 2009), raising the possibility that there may be a common
core of key miR-125 targets that are coordinately repressed in
progenitors and whose activation results in proliferation and
commitment. Of the handful of miR-125b targets described to
date in other cell types, it is intriguing that Bmf, a proapoptotic
miR-125b target in human glioma cells, also appeared on our
shortlist (Xia et al., 2009, no. 1380), as did the p53 regulator
Trp53inp1. While p53 itself is known to be a miR-125b target in
several systems (Le et al., 2009; Xia et al., 2009; Zhang et al.,
2009; Zhou et al., 2010), this merits further investigation in skin,
as it did not surface in our list of putative targets (Table S3). As
future studies are conducted, it will be interesting to evaluate
the extent to which miR-125’s targets will be tailored to suit
the general versus specialized needs of SCs in adult tissues.EXPERIMENTAL PROCEDURES
Mouse Strains and Genetics
Transgenic mice expressing EGFP from a 260 Kb bacterial artificial chromo-
some (BAC) surrounding the Sox9 locus were obtained from the GENSAT
project (GENSTAT, 2008; Gong et al., 2003). The BAC contained 75 Kb
genomic DNA upstream of the Sox9 coding region, which had been replaced
with the EGFP coding sequence. To create K14-RFP/Sox9-EGFP double
transgenic mice, Sox9-EGFP mice were bred to mice regulating RFP expres-
sion under the control of the K14 promoter (Vasioukhin et al., 1999). To
generate TRE-miR-125b, the mmu-miR-125b coding sequence was amplified
by PCR from mouse genomic DNA (Primers 50-TGCAAAGCTTAGACAGAAAT
GAATCTAAATTTTGTG-30 and 50-TGCATCTAGACTCAAGGGTGTATTACCAT
CACTTC-30), cloned into HindIII/Xba1 sites of the pTRE2 plasmid (Clontech)
and sequenced. Transgenic mice were generated as described (Vasioukhin
et al., 1999).
MicroRNA Microarray and Data Analysis
For both miRNA and mRNA microarrays, total RNA samples were extracted
from FACS-sorted cells using the miRNeasy Mini Kit (QIAGEN). For mRNA306 Cell Stem Cell 8, 294–308, March 4, 2011 ª2011 Elsevier Inc.microarray, RNA samples were submitted to the Genomics Core Laboratory
of the Memorial Sloan Kettering Cancer Center for cRNA and Amplification
and analyzed on Affymetrix mouse 430_2 arrays. For microRNA arrays,
samples were submitted to Exiqon. In brief, samples were labeled using the
miRCURY Hy3/Hy5 power labeling kit and hybridized on the miRCURY LNA
Array (v.11.0) (Exiqon). A sample of Early Bulge, ORS, Matrix, or Basal cells
and a reference sample of the corresponding RFP All cells were differentially
labeled and cohybridized on the same array. Dye switches were included.
The normalized signal ratio between sample and reference was used to repre-
sent the relative expression level of eachmiRNA in each sample. Unsupervised
hierarchical clustering analysis was conducted using the cluster software
(Eisen et al., 1998). Low expression miRNAs (raw signal intensity % 100)
were excluded from analyses. miRNA family data were downloaded from the
TargetScan website (Lewis et al., 2003, 2005).
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and three tables and can be
found with this article online at doi:10.1016/j.stem.2011.01.014.
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